In this episode, Scott Becker discusses GAP’s steep stock decline and examines whether tariffs are the real issue or just an excuse for deeper management and product struggles.

In this episode, Scott Becker breaks down seven key business stories, including market movement, rising U.S.-China tensions, how top companies are navigating tariffs, and more.

In this episode, Scott Becker discusses Tempus AI’s rapid growth, recent market moves, and its impact on oncology care.

In this episodes, Scott Becker discusses how routine disruptions, stress, and small triggers can derail healthy habits, and explains why the key to long-term success is getting back on track the very next day.

In this episode, Scott Becker explores the limitations of point solutions in business, emphasizing the importance of offering broader guidance and support to ensure clients can move forward effectively after using a niche service.

In this episode, Scott Becker covers seven top business stories, including NVIDIA’s race with Microsoft for top market cap, Salesforce’s strong AI-driven growth, tariff setbacks affecting U.S. trade policy, and more.

In this episode, Scott Becker talks with McGuireWoods partner David Pivnick about a major constitutional challenge to the False Claims Act, the potential impact on whistleblower lawsuits, and what it could mean for healthcare litigation and government recoveries.

In this episode, Scott Becker discusses Tempus AI’s rapid growth, recent market moves, and its impact on oncology care.

In this episode, Scott Becker dives into two major topics: the surprising global shift in response to Trump’s tariff policies, and Tesla’s remarkable rebound despite sharp declines in international sales.

In this episode, Scott Becker breaks down four key business stories: Tempus AI’s stock drop, major leadership changes at Jeep, Tesla’s recovery under Elon Musk’s renewed focus, and how U.S. trade power is influencing global tariff negotiations.